A recent study suggests that patients who come off blockbuster weight-loss injections like Mounjaro or Wegovy can put back on shed pounds much more quickly than those who end conventional lifestyle plans.
Published data in a leading health publication demonstrates that while obese people often shed about a fifth of their body weight while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Users buying these medications must be informed of the danger of fast rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.
This pace of regain implies a return to starting weight in about one and a half years.
Comparing Therapies
The research, which examined dozens of trials involving thousands of participants, contrasted the results of the injectable medications with conventional dieting.
Scientists point out that people who lose weight through dieting usually have a more gradual creep back—perhaps 0.1 kg a month—after stopping.
Understanding the Quick Regain
Nutrition scientists believe the way of the jabs accounts for the accelerated regain.
The injections copy a natural hormone called glucagon-like peptide-1, which controls appetite.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production may cause the body to produce less of its endogenous hormone, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this hormone supplement leads to hunger is no longer kept in check, making binge eating a significant risk."
An Ongoing Disease?
The NHS recommend the injections for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
Professionals say that, considering the high risk of weight regain, the therapy might need to be ongoing.
This view is supported by pharmaceutical companies, who say that the results "underscore the long-term character of obesity," comparing it to managing diseases like high blood pressure.
User Experiences
Users who have come off the medication report a sudden resurgence of cravings.
"It felt as if something flipping and you become ravenous," recalled a patient.
This difficulty is exacerbated if users have not developed permanent dietary or behavioural modifications during treatment.
Widespread Interest
Recent estimates show that millions of adults in the UK have tried weight-loss jabs in the past year, with desire being substantial.
- Use is higher among women compared to males.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the medications through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while these medications are powerful agents for weight loss, they are not a magic fix and long-term success hinges on combined behavioural changes.
